JULIE KNOCHE: Open Payments
NPI 1336153873 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 48 payments from 14 companies in 2025. Trend: 2023 $1,634 · 2024 $1,267 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $250 |
| GENZYME CORPORATION | 12 | $232 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| GlaxoSmithKline, LLC. | 3 | $75 |
| Amgen Inc. | 3 | $71 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $55 |
| Incyte Corporation | 2 | $48 |
| Blueprint Medicines Corporation | 1 | $32 |
| Genentech USA, Inc. | 2 | $32 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NUCALA, AIRSUPRA, AYVAKIT, NEFFY, OPZELURA.
Industry payments across KS — which companies pay providers there.
